F755 in Wyoming. Pick another state for the same tag.
Against expectation — 2025
Wyoming cites F755 less often than its own record predicts
Versus expected share0.24×
0.24 times the national share — cited less often here than elsewhere.
Share of Wyoming citations0.56%
Of every deficiency written in Wyoming in 2025, this is the portion that was F755.
Wyoming0.56%
National2.35%
Share of all citations that were F755.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Wyoming surveyors wrote
F755 findings written in Wyoming, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
D · No harm, potential for more than minimal, isolatedJuly 30, 2026
Based on medical record review, and staff interview, the facility failed to ensure a pharmaceutical services procedure related to accurate acquiring, receiving, dispensing and administration of medications for 1 of 6 sample residents (#65) reviewed for medication availability. The findings were: 1. Review of a quarterly MDS assessment dated [DATE] showed resident #65 had a BIMS score of 5 out of 15 which indicated severe cognitive impairment, and diagnoses which included Alzheimer's disease, non-Alzheimer's dementia, and seasonal allergic rhinitis. Review of the physician orders showed the resident was to receive Sudafed Sinus Congestion Oral Tablet 1 time a day for sinus congestion. The following concerns were identified: a. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction